Angiotensin II-stimulated collagen synthesis in aortic adventitial fibroblasts is mediated by connective tissue growth factor

Zai Qian Che, Ping Jin Gao, Wei Li Shen, Chunling Fan, Jian Jun Liu, Ding Liang Zhu

Research output: Contribution to journalArticle

Abstract

Anglotensin II (Ang II), a potent mediator of vascular remodeling, can stimulate the synthesis of extrocellular matrix in vascular cells. Recent studies indicate that connective tissue growth factor (CTGF) is involved in collagen synthesis. There is also increasing evidence that adventitial fibroblasts (AFs) are actively involved in vascular remodeling. However, whether collagen synthesis by AFs is mediated by CTGF, or whether it is relevant to Ang II, has not been studied. The present study was conducted to determine whether CTGF is expressed in AFs, and if so, whether the CTGF produced by AFs participates in collagen synthesis. The AFs were isolated from thoracic aorta of Wistar-Kyoto rats (WKY). The expression of CTGF was measured by Western blot or real-time PCR. Collagen synthesis was assessed by [2H]proline incorporation. Our results suggested that CTGF was expressed in AFs and secreted into medium. Ang II increased CTGF mRNA and protein expression in a time- and dose-dependent manner, with the maximal protein increase occurring at 24 h with an Ang II dose of 10-7 mol/L, and this increase was inhibited by the Ang II receptor type 1 (AT1-R) antagonist losartan, but not by the Ang II receptor type 2 (AT2-R) antagonist PD123319. Ang II dose-dependently stimulated the incorporation of [2H]proline into cultured AFs, and this effect was inhibited by a CTGF antisense oligodeoxynucleotide. Overexpression of CTGF by pcDNA3.1(+)/CTGF increased [3H]proline incorporation in cultured AFs. The results demonstrated that, in cultured AFs, Ang II increased CTGF production via AT1-R, Which could be mediators of collagen synthesis by Ang II. This finding suggests that CTGF might be a novel target for antifibrotic therapy in vascular diseases.

Original languageEnglish (US)
Pages (from-to)1233-1240
Number of pages8
JournalHypertension Research
Volume31
Issue number6
DOIs
StatePublished - Jun 2008
Externally publishedYes

Fingerprint

Connective Tissue Growth Factor
Adventitia
Angiotensin II
Collagen
Fibroblasts
Proline
Losartan
Inbred WKY Rats
Oligodeoxyribonucleotides
Thoracic Aorta
Vascular Diseases
Blood Vessels
Real-Time Polymerase Chain Reaction
Proteins

Keywords

  • Angiotensin II
  • Collagen synthesis
  • Connective tissue growth factor
  • Vascular adventitial fibroblasts

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Angiotensin II-stimulated collagen synthesis in aortic adventitial fibroblasts is mediated by connective tissue growth factor. / Che, Zai Qian; Gao, Ping Jin; Shen, Wei Li; Fan, Chunling; Liu, Jian Jun; Zhu, Ding Liang.

In: Hypertension Research, Vol. 31, No. 6, 06.2008, p. 1233-1240.

Research output: Contribution to journalArticle

Che, Zai Qian ; Gao, Ping Jin ; Shen, Wei Li ; Fan, Chunling ; Liu, Jian Jun ; Zhu, Ding Liang. / Angiotensin II-stimulated collagen synthesis in aortic adventitial fibroblasts is mediated by connective tissue growth factor. In: Hypertension Research. 2008 ; Vol. 31, No. 6. pp. 1233-1240.
@article{50c451a98a964c5096c230567e861d9c,
title = "Angiotensin II-stimulated collagen synthesis in aortic adventitial fibroblasts is mediated by connective tissue growth factor",
abstract = "Anglotensin II (Ang II), a potent mediator of vascular remodeling, can stimulate the synthesis of extrocellular matrix in vascular cells. Recent studies indicate that connective tissue growth factor (CTGF) is involved in collagen synthesis. There is also increasing evidence that adventitial fibroblasts (AFs) are actively involved in vascular remodeling. However, whether collagen synthesis by AFs is mediated by CTGF, or whether it is relevant to Ang II, has not been studied. The present study was conducted to determine whether CTGF is expressed in AFs, and if so, whether the CTGF produced by AFs participates in collagen synthesis. The AFs were isolated from thoracic aorta of Wistar-Kyoto rats (WKY). The expression of CTGF was measured by Western blot or real-time PCR. Collagen synthesis was assessed by [2H]proline incorporation. Our results suggested that CTGF was expressed in AFs and secreted into medium. Ang II increased CTGF mRNA and protein expression in a time- and dose-dependent manner, with the maximal protein increase occurring at 24 h with an Ang II dose of 10-7 mol/L, and this increase was inhibited by the Ang II receptor type 1 (AT1-R) antagonist losartan, but not by the Ang II receptor type 2 (AT2-R) antagonist PD123319. Ang II dose-dependently stimulated the incorporation of [2H]proline into cultured AFs, and this effect was inhibited by a CTGF antisense oligodeoxynucleotide. Overexpression of CTGF by pcDNA3.1(+)/CTGF increased [3H]proline incorporation in cultured AFs. The results demonstrated that, in cultured AFs, Ang II increased CTGF production via AT1-R, Which could be mediators of collagen synthesis by Ang II. This finding suggests that CTGF might be a novel target for antifibrotic therapy in vascular diseases.",
keywords = "Angiotensin II, Collagen synthesis, Connective tissue growth factor, Vascular adventitial fibroblasts",
author = "Che, {Zai Qian} and Gao, {Ping Jin} and Shen, {Wei Li} and Chunling Fan and Liu, {Jian Jun} and Zhu, {Ding Liang}",
year = "2008",
month = "6",
doi = "10.1291/hypres.31.1233",
language = "English (US)",
volume = "31",
pages = "1233--1240",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Angiotensin II-stimulated collagen synthesis in aortic adventitial fibroblasts is mediated by connective tissue growth factor

AU - Che, Zai Qian

AU - Gao, Ping Jin

AU - Shen, Wei Li

AU - Fan, Chunling

AU - Liu, Jian Jun

AU - Zhu, Ding Liang

PY - 2008/6

Y1 - 2008/6

N2 - Anglotensin II (Ang II), a potent mediator of vascular remodeling, can stimulate the synthesis of extrocellular matrix in vascular cells. Recent studies indicate that connective tissue growth factor (CTGF) is involved in collagen synthesis. There is also increasing evidence that adventitial fibroblasts (AFs) are actively involved in vascular remodeling. However, whether collagen synthesis by AFs is mediated by CTGF, or whether it is relevant to Ang II, has not been studied. The present study was conducted to determine whether CTGF is expressed in AFs, and if so, whether the CTGF produced by AFs participates in collagen synthesis. The AFs were isolated from thoracic aorta of Wistar-Kyoto rats (WKY). The expression of CTGF was measured by Western blot or real-time PCR. Collagen synthesis was assessed by [2H]proline incorporation. Our results suggested that CTGF was expressed in AFs and secreted into medium. Ang II increased CTGF mRNA and protein expression in a time- and dose-dependent manner, with the maximal protein increase occurring at 24 h with an Ang II dose of 10-7 mol/L, and this increase was inhibited by the Ang II receptor type 1 (AT1-R) antagonist losartan, but not by the Ang II receptor type 2 (AT2-R) antagonist PD123319. Ang II dose-dependently stimulated the incorporation of [2H]proline into cultured AFs, and this effect was inhibited by a CTGF antisense oligodeoxynucleotide. Overexpression of CTGF by pcDNA3.1(+)/CTGF increased [3H]proline incorporation in cultured AFs. The results demonstrated that, in cultured AFs, Ang II increased CTGF production via AT1-R, Which could be mediators of collagen synthesis by Ang II. This finding suggests that CTGF might be a novel target for antifibrotic therapy in vascular diseases.

AB - Anglotensin II (Ang II), a potent mediator of vascular remodeling, can stimulate the synthesis of extrocellular matrix in vascular cells. Recent studies indicate that connective tissue growth factor (CTGF) is involved in collagen synthesis. There is also increasing evidence that adventitial fibroblasts (AFs) are actively involved in vascular remodeling. However, whether collagen synthesis by AFs is mediated by CTGF, or whether it is relevant to Ang II, has not been studied. The present study was conducted to determine whether CTGF is expressed in AFs, and if so, whether the CTGF produced by AFs participates in collagen synthesis. The AFs were isolated from thoracic aorta of Wistar-Kyoto rats (WKY). The expression of CTGF was measured by Western blot or real-time PCR. Collagen synthesis was assessed by [2H]proline incorporation. Our results suggested that CTGF was expressed in AFs and secreted into medium. Ang II increased CTGF mRNA and protein expression in a time- and dose-dependent manner, with the maximal protein increase occurring at 24 h with an Ang II dose of 10-7 mol/L, and this increase was inhibited by the Ang II receptor type 1 (AT1-R) antagonist losartan, but not by the Ang II receptor type 2 (AT2-R) antagonist PD123319. Ang II dose-dependently stimulated the incorporation of [2H]proline into cultured AFs, and this effect was inhibited by a CTGF antisense oligodeoxynucleotide. Overexpression of CTGF by pcDNA3.1(+)/CTGF increased [3H]proline incorporation in cultured AFs. The results demonstrated that, in cultured AFs, Ang II increased CTGF production via AT1-R, Which could be mediators of collagen synthesis by Ang II. This finding suggests that CTGF might be a novel target for antifibrotic therapy in vascular diseases.

KW - Angiotensin II

KW - Collagen synthesis

KW - Connective tissue growth factor

KW - Vascular adventitial fibroblasts

UR - http://www.scopus.com/inward/record.url?scp=48449094243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48449094243&partnerID=8YFLogxK

U2 - 10.1291/hypres.31.1233

DO - 10.1291/hypres.31.1233

M3 - Article

C2 - 18716373

AN - SCOPUS:48449094243

VL - 31

SP - 1233

EP - 1240

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 6

ER -